MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/03009742.2016.1194457

Медицинская библиотека · Scandinavian journal of rheumatology · 2016

Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.

Lesuis N, Verhoef L M, Nieboer L M, Bruyn G A, Baudoin P, van Vollenhoven R F, Hulscher Mejl, van den Hoogen Fhj, den Broeder A A

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

To assess the effects of education, guideline development, and individualized treatment advice on rheumatologist adherence to tight control-based treatment and biological dose optimization in rheumatoid arthritis (RA), psoriatic arthritis (PsA), and spondyloarthropathy (SpA) patients.

METHOD: This pilot study, among two rheumatologists and two specialized nurses in a general hospital, combined education, feedback, local guideline development, and individualized treatment advice. Outcomes (baseline and 1 year post-intervention) were the percentage of patients with a Disease Activity Score in 28 joints (DAS28) or Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) measured during the visit, mean DAS28/BASDAI, and the percentage of patients using a reduced biological dose. DAS28 outcomes only applied to RA and PsA patients, BASDAI outcomes only applied to SpA patients whereas outcomes on biological dose applied to all patients.

RESULTS

A total of 232 patients (67% RA, 15% PsA, 18% SpA; 58% female, mean age 56 ± 15 years) were included in the study. The percentage of DAS28 and BASDAI measurements performed increased after the intervention [DAS28 15-51%, odds ratio (OR) 3.3, 95% confidence interval (CI) 2.1-5.5; BASDAI 23-50%, OR 2.2, 95% CI 1.0-5.5], with mean DAS28 and BASDAI scores remaining similar (DAS28: mean difference 0.1, 95% CI -0.3 to 0.5; BASDAI: mean difference 0.03, 95% CI -1.8 to 1.9). Use of a reduced biological dose increased from 10% to 61% (OR 3.9, 95% CI 2.4-6.5).

CONCLUSIONS

A multicomponent intervention strategy aimed at rheumatologists can lead to improved adherence to tight control-based treatment and a reduction in the use of biologicals in RA, SpA, and PsA patients.

Для цитирования: Lesuis N, Verhoef L M, Nieboer L M, Bruyn G A, Baudoin P, van Vollenhoven R F, Hulscher Mejl, van den Hoogen Fhj, den Broeder A A. Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.. Scandinavian journal of rheumatology. 2016. DOI: 10.1080/03009742.2016.1194457.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.